Cargando…

Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones

The search for effective treatments against COVID-19 in the current pandemic has presented the scientific community with an enormous challenge. In fact, there is still no effective treatment for SARS-CoV-2 infection, apart from supportive measures. Research has focused on re-examining antiviral drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Iglesias, Mercedes, Benavent, Eva, Murillo, Óscar, Luis Ferreiro, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Cardiología. Published by Elsevier España, S.L. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668175/
http://dx.doi.org/10.1016/S1131-3587(20)30033-9
_version_ 1783610441677668352
author Iglesias, Mercedes
Benavent, Eva
Murillo, Óscar
Luis Ferreiro, José
author_facet Iglesias, Mercedes
Benavent, Eva
Murillo, Óscar
Luis Ferreiro, José
author_sort Iglesias, Mercedes
collection PubMed
description The search for effective treatments against COVID-19 in the current pandemic has presented the scientific community with an enormous challenge. In fact, there is still no effective treatment for SARS-CoV-2 infection, apart from supportive measures. Research has focused on re-examining antiviral drugs that were previously used against other viral infections and on the use of anti-inflammatories, since COVID-19 patients can develop a hyperinflammatory state, which is associated with a poorer disease prognosis. However, these drugs, sometimes administered on a compassionate-use basis, can cause serious side effects or drug interactions that we should be aware of. The aim of this article is to provide an overview of what is currently known about the pharmacological therapies most frequently used against COVID-19 in our field, while paying particular attention to the adverse events and drug interactions that can affect the cardiovascular system.
format Online
Article
Text
id pubmed-7668175
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedad Española de Cardiología. Published by Elsevier España, S.L.
record_format MEDLINE/PubMed
spelling pubmed-76681752020-11-16 Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones Iglesias, Mercedes Benavent, Eva Murillo, Óscar Luis Ferreiro, José Revista Española de Cardiología Suplementos Article The search for effective treatments against COVID-19 in the current pandemic has presented the scientific community with an enormous challenge. In fact, there is still no effective treatment for SARS-CoV-2 infection, apart from supportive measures. Research has focused on re-examining antiviral drugs that were previously used against other viral infections and on the use of anti-inflammatories, since COVID-19 patients can develop a hyperinflammatory state, which is associated with a poorer disease prognosis. However, these drugs, sometimes administered on a compassionate-use basis, can cause serious side effects or drug interactions that we should be aware of. The aim of this article is to provide an overview of what is currently known about the pharmacological therapies most frequently used against COVID-19 in our field, while paying particular attention to the adverse events and drug interactions that can affect the cardiovascular system. Sociedad Española de Cardiología. Published by Elsevier España, S.L. 2020 2020-11-16 /pmc/articles/PMC7668175/ http://dx.doi.org/10.1016/S1131-3587(20)30033-9 Text en Copyright © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Iglesias, Mercedes
Benavent, Eva
Murillo, Óscar
Luis Ferreiro, José
Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
title Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
title_full Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
title_fullStr Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
title_full_unstemmed Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
title_short Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
title_sort tratamientos farmacológicos de los pacientes con covid19: interacciones e indicaciones
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668175/
http://dx.doi.org/10.1016/S1131-3587(20)30033-9
work_keys_str_mv AT iglesiasmercedes tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones
AT benaventeva tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones
AT murillooscar tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones
AT luisferreirojose tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones